Jun 24, 2021

Starpharma to present at Virtual Life Sciences Investor Forum (ASX Announcement)

Starpharma to present at Virtual Life Sciences Investor Forum (ASX Announcement)

Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that a presentation by Dr Jackie Fairley, CEO, will be broadcast on Thursday 24 June 2021 (US ET) as part of OTCQX’s Virtual Life Sciences Investor Forum. The Life Sciences Investor Forum is a leading investor conference that is attended by tens of thousands of investors, primarily US-based retail investors, as well as advisors.

Details of the forum are found via this link: Virtual Life Sciences Investor Forum. Starpharma’s pre-recorded presentation features a company overview, including the latest updates on the VIRALEZE™ Antiviral Nasal Spray which has shown potent antiviral activity against multiple variants of coronavirus/SARS-CoV-2 in laboratory studies, and has been registered in Europe (launched) and India. The presentation will also include an overview of Starpharma’s DEP® clinical-stage and preclinical assets, and corporate partnerships for its DEP® drug delivery platform, including with Merck & Co., Inc (MSD) and AstraZeneca, as well as its VivaGel® products, which are approved in more than 45 countries. The presentation is attached and also available on Starpharma’s website.

Download ASX Announcement: Starpharma to present at Virtual Life Sciences Investor Forum (pdf file, 7MB)

 This contains certain forward-looking statements.